AI assistant
CYTOKINETICS INC — Director's Dealing 2011
May 19, 2011
30870_dirs_2011-05-19_244d6724-7766-4ae9-920a-e13f6e0d20fe.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2011-05-18
Reporting Person: GILBERT DENISE (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-05-18 | Non-Qualified Stock Option (right to buy) | $1.44 | A | 20000 | Acquired | 2021-05-18 | Common Stock (20000) | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy) | $1.85 | 2019-05-21 | Common Stock (15000) | 15000 | Direct |
| Non-Qualified Stock Option (right to buy) | $2.81 | 2020-05-20 | Common Stock (20000) | 20000 | Direct |
| Non-Qualified Stock Option (right to buy) | $3.87 | 2018-05-14 | Common Stock (30000) | 30000 | Direct |
Footnotes
F1: This option shall vest and become exercisable as to 20,000 shares divided into equal monthly installments such that the option shall be 100% vested on May 18, 2012.
F2: This option shall vest and become exercisable as to 15,000 shares divided into equal monthly installments such that the option shall be 100% vested on May 21, 2010.
F3: This option shall vest and become exercisable as to 20,000 shares divided into equal monthly installments such that the option shall be 100% vested on May 20, 2011.
F4: This option shall vest and become exercisable as to 833 shares on 06/14/08 and the balance of 29,167 divided into equal monthly installments thereafter such that the option shall be 100% vested on 05/14/11.